English | Español

Biospace
Patient Daily | Mar 16, 2026

Ipsen withdraws Tazverik cancer drug after safety concerns in clinical trial
Patient Daily | Mar 16, 2026

FDA rejects Incyte’s lung cancer drug application due to issues at Catalent Indiana site
Patient Daily | Mar 16, 2026

AbbVie reports early trial results for weight loss drug ABBV-295
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
Patient Daily | Mar 16, 2026

Novo Nordisk to sell GLP-1 drugs through Hims & Hers after ending legal dispute

Trending
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health